Statistical correlation doesn't imply causality. They just go together naturally.
Resolution 3 doesn't generate new funds. We have to approve the shares they already sold for some reason. I can't explain why we have to approve the prior shares but PRAN probably screwed up somehow and exceeded their number of shares or something and we now have to get shareholders to approve the sale. Questions come to mind like what happens to those shares if they aren't approved and do the people holding those shares get to vote for approval?
Here's one that's interesting:
OC49. Cognitive decline, hippocampal atrophy and amyloid accumulation in preclinical and prodromal AD : Clinical trial implications
Paul Maruff, PhD 1,2,6, Yen Ying Lim2, Robert H. Pietrzak3, David Ames4, 6 Kathryn A. Ellis4, 6, Colin L. Masters2,4,6, Christopher C. Rowe5, 6, Victor L. Villemagne5, 6.
(1) CogState Ltd (2) The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia. (3) Yale University Medical School, (4) The University of Melbourne (5) Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia (6) For the AIBL Research Group
OK, everyone keeps saying "off-label" use for AD. Who's going to pay out pf pocket the 5-10K per MONTH PBT2 out of thier own pocket. Off label won't be covered by insurance and the orphan designation means the price will be VERY HIGH. There won't be much off label use I would say..
What he's saying it Tanzi knew before the Imagine results that PBT2 did well in his matrix. My problem is the Imagine results were not good. So what does that say about how well the matrix will relate to real in-patient testing?
They just sold 3 million shares for 6.83 to lincoln as part of the prior financing deal. Price of the shares obviously set for the close of the day before results announced so they get a good price.
I like the ending paragraph:
“Our goal was to prevent further progression of the disease, not reverse it and see visual improvement,” says Lanza. “But seeing the improvement in vision was frosting on the cake.”